Literature DB >> 22460981

Detection of infectious influenza virus in cough aerosols generated in a simulated patient examination room.

John D Noti1, William G Lindsley, Francoise M Blachere, Gang Cao, Michael L Kashon, Robert E Thewlis, Cynthia M McMillen, William P King, Jonathan V Szalajda, Donald H Beezhold.   

Abstract

BACKGROUND: The potential for aerosol transmission of infectious influenza virus (ie, in healthcare facilities) is controversial. We constructed a simulated patient examination room that contained coughing and breathing manikins to determine whether coughed influenza was infectious and assessed the effectiveness of an N95 respirator and surgical mask in blocking transmission.
METHODS: National Institute for Occupational Safety and Health aerosol samplers collected size-fractionated aerosols for 60 minutes at the mouth of the breathing manikin, beside the mouth, and at 3 other locations in the room. Total recovered virus was quantitated by quantitative polymerase chain reaction and infectivity was determined by the viral plaque assay and an enhanced infectivity assay.
RESULTS: Infectious influenza was recovered in all aerosol fractions (5.0% in >4 μm aerodynamic diameter, 75.5% in 1-4 μm, and 19.5% in <1 μm; n = 5). Tightly sealing a mask to the face blocked entry of 94.5% of total virus and 94.8% of infectious virus (n = 3). A tightly sealed respirator blocked 99.8% of total virus and 99.6% of infectious virus (n = 3). A poorly fitted respirator blocked 64.5% of total virus and 66.5% of infectious virus (n = 3). A mask documented to be loosely fitting by a PortaCount fit tester, to simulate how masks are worn by healthcare workers, blocked entry of 68.5% of total virus and 56.6% of infectious virus (n = 2).
CONCLUSIONS: These results support a role for aerosol transmission and represent the first reported laboratory study of the efficacy of masks and respirators in blocking inhalation of influenza in aerosols. The results indicate that a poorly fitted respirator performs no better than a loosely fitting mask.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22460981      PMCID: PMC4680957          DOI: 10.1093/cid/cis237

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Experimental exposure of human subjects to viruses of influenza.

Authors:  W HENLE; G HENLE
Journal:  J Immunol       Date:  1946-02       Impact factor: 5.422

2.  Measurement of airborne influenza virus in a hospital emergency department.

Authors:  Francoise M Blachere; William G Lindsley; Terri A Pearce; Stacey E Anderson; Melanie Fisher; Rashida Khakoo; Barbara J Meade; Owen Lander; Stephen Davis; Robert E Thewlis; Ismail Celik; Bean T Chen; Donald H Beezhold
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

Review 3.  Transmission of influenza A in human beings.

Authors:  Gabrielle Brankston; Leah Gitterman; Zahir Hirji; Camille Lemieux; Michael Gardam
Journal:  Lancet Infect Dis       Date:  2007-04       Impact factor: 25.071

4.  Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model.

Authors:  Taronna R Maines; Li-Mei Chen; Yumiko Matsuoka; Hualan Chen; Thomas Rowe; Juan Ortin; Ana Falcón; Tran Hien Nguyen; Le Quynh Mai; Endang R Sedyaningsih; Syahrial Harun; Terrence M Tumpey; Ruben O Donis; Nancy J Cox; Kanta Subbarao; Jacqueline M Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-31       Impact factor: 11.205

Review 5.  Aerosol transmission of influenza A virus: a review of new studies.

Authors:  Raymond Tellier
Journal:  J R Soc Interface       Date:  2009-09-22       Impact factor: 4.118

6.  Measurements of airborne influenza virus in aerosol particles from human coughs.

Authors:  William G Lindsley; Francoise M Blachere; Robert E Thewlis; Abhishek Vishnu; Kristina A Davis; Gang Cao; Jan E Palmer; Karen E Clark; Melanie A Fisher; Rashida Khakoo; Donald H Beezhold
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

7.  Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

Authors:  Vincent J Munster; Emmie de Wit; Judith M A van den Brand; Sander Herfst; Eefje J A Schrauwen; Theo M Bestebroer; David van de Vijver; Charles A Boucher; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2009-07-02       Impact factor: 47.728

8.  Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.

Authors:  Nicole M Bouvier; Anice C Lowen; Peter Palese
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

9.  Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks.

Authors:  Donald K Milton; M Patricia Fabian; Benjamin J Cowling; Michael L Grantham; James J McDevitt
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

10.  Influenza virus in human exhaled breath: an observational study.

Authors:  Patricia Fabian; James J McDevitt; Wesley H DeHaan; Rita O P Fung; Benjamin J Cowling; Kwok Hung Chan; Gabriel M Leung; Donald K Milton
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  63 in total

1.  Airborne transmission of influenza: implications for control in healthcare and community settings.

Authors:  Benjamin J Cowling
Journal:  Clin Infect Dis       Date:  2012-03-29       Impact factor: 9.079

2.  Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.

Authors:  Francoise M Blachere; William G Lindsley; Cynthia M McMillen; Donald H Beezhold; Edward M Fisher; Ronald E Shaffer; John D Noti
Journal:  J Virol Methods       Date:  2018-07-17       Impact factor: 2.014

3.  The ongoing battle against influenza: The challenge of flu transmission.

Authors:  Seema S Lakdawala; Kanta Subbarao
Journal:  Nat Med       Date:  2012-10       Impact factor: 53.440

4.  Authors' Reply. MERS-CoV, surgical mask and N95 respirators.

Authors:  Jasmine Shimin Chung; Moi Lin Ling; Wing Hong Seto; Brenda Sze Peng Ang; Paul Anantharajah Tambyah
Journal:  Singapore Med J       Date:  2014-09       Impact factor: 1.858

5.  Barrier Devices, Intubation, and Aerosol Mitigation Strategies: PPE in the Time of COVID-19.

Authors:  Eric A Fried; George Zhou; Ronak Shah; Da Wi Shin; Anjan Shah; Daniel Katz; Garrett W Burnett
Journal:  Anesth Analg       Date:  2020-09-15       Impact factor: 5.108

6.  Reply.

Authors:  Rupsa C Boelig; Federica Bellussi; Vincenzo Berghella
Journal:  Am J Obstet Gynecol MFM       Date:  2020-06-15

7.  N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.

Authors:  Lewis J Radonovich; Michael S Simberkoff; Mary T Bessesen; Alexandria C Brown; Derek A T Cummings; Charlotte A Gaydos; Jenna G Los; Amanda E Krosche; Cynthia L Gibert; Geoffrey J Gorse; Ann-Christine Nyquist; Nicholas G Reich; Maria C Rodriguez-Barradas; Connie Savor Price; Trish M Perl
Journal:  JAMA       Date:  2019-09-03       Impact factor: 56.272

8.  Development and Performance Evaluation of an Exhaled-Breath Bioaerosol Collector for Influenza Virus.

Authors:  James J McDevitt; Petros Koutrakis; Stephen T Ferguson; Jack M Wolfson; M Patricia Fabian; Marco Martins; Jovan Pantelic; Donald K Milton
Journal:  Aerosol Sci Technol       Date:  2013-01-25       Impact factor: 2.908

Review 9.  Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis.

Authors:  Jeffrey D Smith; Colin C MacDougall; Jennie Johnstone; Ray A Copes; Brian Schwartz; Gary E Garber
Journal:  CMAJ       Date:  2016-03-07       Impact factor: 8.262

10.  Validation and application of models to predict facemask influenza contamination in healthcare settings.

Authors:  Edward M Fisher; John D Noti; William G Lindsley; Francoise M Blachere; Ronald E Shaffer
Journal:  Risk Anal       Date:  2014-03-04       Impact factor: 4.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.